Restricted accessResearch articleFirst published online 2009-10
A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin,ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis
This study was designed to compare the efficacy of ciprofloxacin plus rifampin (CR) and ciprofloxacin plus doxycycline (CD) versus doxycycline plus rifampin (DR) in the treatment of brucellosis. A total of 178 patients with brucellosis who were referred to the Sina Hospital, Hamedan, Iran, were included. The responses to therapy were observed in 166 cases (93.7%) – 59 were in the DR group, 59 in the CR group and 48 in the CD group. No significant differences in the therapeutic responses were observed (P = 0.09). Relapse was observed in 11.7% (DR 7.7%, CR 8.3% and CD 17.5%) after a six-month follow-up. No significant differences were also observed in relapse rates among the three groups (P = 0.35). We concluded that DR is still the first choice regimen and CR or CD may be used as alternatives for treatment of brucellosis in adults.
Get full access to this article
View all access options for this article.
References
1.
YoungEJ. Brucella Species. In: MandelGL, BennetJE, DolinR, eds. Mandell, Douglas, and Bennet's Principles and Practice of Infectious Diseases. 6th edn.Philadelphia: Elsevier Churchill Livingstone, 2005:2669–74
Jow-AfshaniMA, ZowghiE, SimaniS, Major Zoonoses in Iran. Tehran: Ministry of Health, 2005(in Persian)
4.
PanahiM. Common Disease Epidemiology in Iran. Medical University of Shahid Beheshti. Tehran: University Publication, 1993(in Persian)
5.
ArizaJ, BosilkovskiM, CascioA, Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med2007;4:e317
6.
ZowghiE, EbadiA. Typing of Brucella strains isolated in Iran. Arch Inst Razi1997;34:154–5
7.
PappasG, AkritidisN, BosilkovskiM, TsianosE. Brucellosis. New Engl J Med2005;352:2325–36
8.
ErsoyY, SonmezE, TevfikMR, Comparison of three different combination therapies in the treatment of human brucellosis. Trop Doct2005;35:210–2
9.
PappasG, ChristouL, AkritidisN, Quinolones for brucellosis: treating old diseases with new drugs. Clin Microbiol Infect2006;12:823–5
10.
AlpE, KocRK, DurakAC, Doxycycline plus streptomycin versus ciprofloxacin plus rifampicin in spinal brucellosis. BMC Infect Dis2005;6:72
11.
SauretJm, VilissovaN. Human brucellosis. J Am Board Fam Pract2002;15:401–6
12.
SoleraJ, Martineza-AlfaroE, EspinosaA. Recognition and optimal treatment of brucellosis. Drugs1997;53:245–56
13.
DoganayM, AyagenB. Human brucellosis: An overview. Int J Infect Dis2003;7:173–82
14.
AygenB, DoganayM, SumerkanB, Clinical manifestations, complications and treatment of brucellosis: an evaluation of 480 patients. Med Mal Infect2002;32:485–93
15.
BosilkovskiM, KrtevaL, DimzovaM, Brucellosis in 418 patients from the Balkan Peninsula: exposure-related differences in clinical manifestations, aboratory test results, and therapy outcome. Int J Infect Dis2007;11:342–47
16.
KarabayO, SencanI, KayasD, Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial. BMC Infect Dis2004;4:18
17.
AkovaM, UzunO, AkalinHE, HayranM, UnalS, GurD. Quinolones in treatment of human brucellosis:comparative trial of ofloxacin- rifampin versus doxycyclin. Antimicrob Agents Chemother1993;37:1831–4
18.
AgalarC, UsubutunS, TurkyilmazR. Ciprofloxacin- rifampicin versus doxycycline and rifampicin in the treatment of Brucellosis. Eur J Clin Microbiol Infect Dis1999;18:535–38
19.
RanjbarM, KeramatF, Mamani, Comparison between doxycyclin-rifampin–amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. Int J Infect Dis2007;11:152–6
20.
DoganayM, AygenB. Use of ciprofloxacin in treatment of brucellosis. Eur J Clin Microbiol Infect Dis1992;11:74–5
21.
LangR, RazR, SacksT, Failure of prolonged treatment with ciprofloxacin in acute brucellosis. J Antimicrob Chemther1990;6:841–6
22.
SaltogluN, TasovaY, PinalAS, Efficacy of rifamipicin plus doxycycline versus rifampicin plus quinolone in the treatment of brucellosis. Saudi Med J2002;23:921–4
23.
SoleraJ, Rodriguez-zapataM, GeijoP, Doxycycline–rifampin versus doxycycline-streptpmycin in treatment of human brucellosis due to Brucella melitensis. Antimicrob Agents Chemother1995;39:2061–7
24.
SoleraJ, GeijoP, LargoJ, A randomized, double-blind study to assess the optimal duration of doxycycline treatment for human brucellosis. Clin Infect Dis2004;39:1776–82
